In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: the Supreme Court’s decision to deny an emergency appeal to block enforcement of a controversial Texas abortion law (00:35), a recent report on Medicare hospital fund insolvency (03:25), and an FDA committee meeting on complex gene therapy safety questions (11:11).
Advancing Health Equity with FemTech feat. HelloGina
March 23, 2023
The FemTech sector has seen major growth in the last 5 years – and as the healthcare industry increases its focus on equity, is only projected to keep growing. In this Women’s History Month episode, Jen is joined by Vynamic’s Diana Kuritza, Jen Proietti-Fox, Shari Robbins, and HelloGina’s Daphne Petrich to discuss the latest trends …
On this week’s Trending News EU episode, Jack and Ollie discuss a few recent EU-based newsworthy items including a third stem cell transplant patient cured of HIV (00:40), NHS approval and investment in digital mental health therapies (04:37), a recent poll on patient centricity in biopharma (08:22), and the announcement of a Moderna campus in …
In this episode, Jen is joined by Vynamic’s Michael Hudson, Mike Cottone, and Vish Kaushik to discuss a major news item that has had everyone buzzing over the last few months – ChatGPT. Podcast Tags: healthcare, healthcare news, AI, artificial intelligence, healthcare technology, health plans, providers, life sciences Source Links: Top 10 Applications of OpenAI’s …
The Chief Marketing Officer of a prescription digital therapeutics (PDT) company was seeking to prepare the organization for future launches. Read how Vynamic leveraged both Healthcare Technology and Life Sciences expertise to build a detailed, practical launch playbook used to expand commercialization in both products and patient types.
Self-Funded Employers: Considerations for Health Plans in 2023
March 2, 2023
In the United States, most employers choose to pay for at least some of their workers’ health services directly from their own funds. Lately, concerns over affordability have led them to take an increasingly active role in their healthcare strategies. In this episode, Jen is joined by Vynamic Director Kirsten Meisterling and Executive & Head …
Integrating Commercial Operations of Two Large Biopharma Companies
Following the acquisition of a large company, Vynamic’s global biopharmaceutical client needed to integrate the people, processes, and technology from both organizations into a new, unified Commercial Operations group. Read how Vynamic provided the collaborative leadership and deep expertise to successfully combine the organizations through enhanced ways of working and common technologies.
Seamlessly Integrating Newly Acquired Brands Into an Established Portfolio
Following an acquisition, a global biopharmaceutical company needed to consolidate disparate brands into a single portfolio and enable a new brands director. Read how Vynamic completed a comprehensive assessment and knowledge transfer to enable the new director to lead the portfolio and implement recommended improvements.
Concurrent Integration Strategy & Execution for Two Fast-Paced Acquisitions
In the midst of integrating one company from a prior deal, a mid-sized pharmaceutical organization made an additional acquisition with a narrow timeframe to complete the integration to meet contractual obligations. Read how Vynamic adapted plans and led a range of activities to meet the original target integration dates despite significant client resource constraints.
Read how a European-based regional HR organization within a Global Pharmaceutical company asked Vynamic to assess the current state of Diversity, Equity, & Inclusion (DEI) across their local countries with the goal of developing a recommended DEI operating model, strategy, and implementation plan.
